Spatially encoded biological assays

Patent metadata

Field	Value
Publication number	US-12391979-B2
Application number	US-202519073932-A
Country	US
Kind code	B2
Filing date	Mar 7, 2025
Priority date	Apr 5, 2010
Publication date	Aug 19, 2025
Grant date	Aug 19, 2025

Abstract

The present invention provides assays and assay systems for use in spatially encoded biological assays. The invention provides an assay system comprising an assay capable of high levels of multiplexing where reagents are provided to a biological sample in defined spatial patterns; instrumentation capable of controlled delivery of reagents according to the spatial patterns; and a decoding scheme providing a readout that is digital in nature.

First claim

The invention claimed is:

1. A system comprising:
an imaging apparatus configured to obtain an image of a tissue section on a substrate comprising encoded probes, wherein the encoded probes comprise coding tags and nucleic acid sequences that interact with target biological molecules;
a microcircuit arrangement configured to obtain information about the tissue section based on the obtained image;
a substrate holder comprising an open gasket configured to receive a reagent into the open gasket, and wherein the tissue section is disposed on the substrate within the open gasket.

2. The system of claim 1 , wherein the microcircuit arrangement is configured to display the obtained image on a display device.

3. The system of claim 1 , wherein the system further comprises a delivery apparatus comprising fluidic channels, wherein the delivery apparatus is configured to deliver a wash fluid through the fluidic channels to the tissue section.

4. The system of claim 1 , wherein the coding tags comprise sequences that correspond to a location of the encoded probes on the substrate.

5. The system of claim 4 , wherein the microcircuit arrangement is configured to separately obtain sequence information of the coding tags, or complements thereof, and the target biological molecules, or complements thereof.

6. The system of claim 5 , wherein the microcircuit arrangement is configured to identify the target biological molecules in the tissue section based on the sequence information.

7. The system of claim 1 , wherein the tissue section comprises a fresh-frozen or formalin-fixed paraffin-embedded tissue section.

8. The system of claim 1 , wherein the target biological molecules comprise nucleic acids.

9. The system of claim 8 , wherein the nucleic acids comprise DNA.

10. The system of claim 8 , wherein the nucleic acids comprise RNA.

11. The system of claim 1 , wherein the target biological molecules comprise proteins or peptides.

12. The system of claim 8 , wherein the microcircuit arrangement is configured to generate a map of the nucleic acids in the tissue section.

13. The system of claim 1 , wherein the microcircuit arrangement is configured to determine abundances of at least some of the target biological molecules in the tissue section.

14. The system of claim 1 , wherein the microcircuit arrangement is configured to identify more than 100 unique target biological molecules in the tissue section.

15. The system of claim 14 , wherein the microcircuit arrangement is configured to identify more than 500 unique target biological molecules in the tissue section.

16. The system of claim 1 , wherein the microcircuit arrangement is configured to determine at least one region of interest of the tissue section from differentiated staining of the tissue section identified in the image of the tissue section.

17. The system of claim 3 , wherein the delivery apparatus is configured to deliver amplification reagents to the tissue section.

18. The system of claim 1 , wherein the open gasket is configured to surround the tissue section.

19. The system of claim 3 , wherein the delivery apparatus is configured to deliver one or more reagents to a surface of the tissue section.

20. The system of claim 3 , wherein the delivery apparatus comprises a pump configured to drive fluid flow to deliver one or more reagents.

Assignees

• Prognosys Biosciences Inc

Inventors

• Chee Mark S

Classifications

• G01N2458/40

  Rare earth chelates · CPC title

• G01N33/6848

  Methods of protein analysis involving mass spectrometry · CPC title

• C12Q2600/158

  Expression markers · CPC title

• C12Q2600/156

  Polymorphic or mutational markers · CPC title

• C12Q1/6858

  Allele-specific amplification · CPC title